Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Combinatorial lead optimization of a neuropeptide FF antagonist
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combinatorial lead optimization of a neuropeptide FF antagonist'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Amino Acids
33%
Anti-opioid
33%
Central Nervous System
33%
Combinatorial Optimization
33%
Competitive Binding
33%
Cysteine
33%
Dansyl
66%
Dimethylamino
66%
Glutamine
33%
High Affinity
33%
Lead Optimization
100%
Mixing Method
33%
Neuropeptide FF
100%
NPFF Receptors
33%
Opiate Withdrawal
33%
Phase Split
33%
Proline
33%
Proline Residue
33%
Secondary Amino Group
33%
Solid Phase
33%
Systemic Administration
33%
Therapeutic Leads
33%
Tripeptide
33%
Chemistry
Amino Acid
33%
Arginine
66%
Cysteine
33%
Glutamine
33%
Gly-Ser
33%
Lead Compound
33%
Neuropeptide FF
100%
Pro-Gln
33%
Proline
33%
Proline Residue
33%
Secondary Amino Group
33%
Tripeptide
33%